Archives of Pediatric Infectious Diseases

Published by: Kowsar

Investigation of Glycopeptide Susceptibility of Coagulase-Negative Staphylococci (CoNS) From a Tertiary Care Hospital in Gorgan, Northern Iran

Hamideh Mehri 1 , Roghaye Jahanbakhsh 1 , Fatemeh Shakeri 2 , Abdollah Ardebili 1 , 3 , Naser Behnampour 4 , Behnaz Khodabakhshi 5 and Ezzat Allah Ghaemi 1 , 3 , *
Authors Information
1 Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran
2 Department of Microbiology, Mazandaran University of Medical Sciences, Sari, Iran
3 Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4 School of Health, Golestan University of Medical Sciences, Gorgan, Iran
5 Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2017, 5 (1); e37264
  • Published Online: July 16, 2016
  • Article Type: Research Article
  • Received: February 20, 2016
  • Revised: May 31, 2016
  • Accepted: June 11, 2016
  • DOI: 10.5812/pedinfect.37264

To Cite: Mehri H, Jahanbakhsh R, Shakeri F, Ardebili A, Behnampour N, et al. Investigation of Glycopeptide Susceptibility of Coagulase-Negative Staphylococci (CoNS) From a Tertiary Care Hospital in Gorgan, Northern Iran, Arch Pediatr Infect Dis. 2017 ; 5(1):e37264. doi: 10.5812/pedinfect.37264.

Abstract
Copyright © 2016, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Harris LG, Foster SJ, Richards RG. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater. 2002; 4: 39-60[PubMed]
  • 2. Martinko JM, Madigan MT. Brock biology of microorganisms. 2005;
  • 3. Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014; 27(4): 870-926[DOI][PubMed]
  • 4. Mayhall CG. Hospital epidemiology and infection control. 2004; : 495-510
  • 5. Tan TY, Ng SY, Ng WX. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J Clin Microbiol. 2006; 44(9): 3413-4[DOI][PubMed]
  • 6. Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013; 2013: 586076[DOI][PubMed]
  • 7. Bannerman TL. Manual of clinical microbiology. 2003; : 384
  • 8. Xu Z, Mkrtchyan HV, Cutler RR. Antibiotic resistance and mecA characterization of coagulase-negative staphylococci isolated from three hotels in London, UK. Front Microbiol. 2015; 6: 947[DOI][PubMed]
  • 9. Winn WC, Koneman EW. Koneman's color atlas and textbook of diagnostic microbiology. 2006;
  • 10. Paiva RM, Mombach Pinheiro Machado AB, Zavascki AP, Barth AL. Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods. J Clin Microbiol. 2010; 48(12): 4652-4[DOI][PubMed]
  • 11. Zhang Y, Fu Y, Yu J, Ai Q, Li J, Peng N, et al. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo. J Infect Chemother. 2015; 21(11): 808-15[DOI][PubMed]
  • 12. Sirichoat A, Wongthong S, Kanyota R, Tavichakorntrakool R, Chanawong A, Welbat JU, et al. Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus. Jundishapur J Microbiol. 2016; 9(1)[DOI][PubMed]
  • 13. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987; 316(15): 927-31[DOI][PubMed]
  • 14. Krcmery VJ, Trupl J, Spanik S. Bacteremia due to teicoplanin-resistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin. Infection. 1997; 25(1): 51-2[PubMed]
  • 15. Tacconelli E, Tumbarello M, Donati KG, Bettio M, Spanu T, Leone F, et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis. 2001; 33(10): 1628-35[DOI][PubMed]
  • 16. Boneca IG, Chiosis G. Vancomycin resistance: occurrence, mechanisms and strategies to combat it. Expert Opin Ther Targets. 2003; 7(3): 311-28[DOI][PubMed]
  • 17. Palazzo IC, Araujo ML, Darini AL. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol. 2005; 43(1): 179-85[DOI][PubMed]
  • 18. Iweriebor BC, Ramalivhana NJ, Hattori T, Okoh AI, Obi CL. Vancomycin resistant coagulase-negative Staphylococcal isolates from HIV positive patients in the Limpopo Province, South Africa. J Microbiol Antimicrob. 2013; 5(2): 18-24
  • 19. Valencia-Rey P, Weinberg J, Miller NS, Barlam TF. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy? J Infect. 2015; 71(1): 53-60[DOI][PubMed]
  • 20. Jorgensen JH, Turnidge JD, Washington J. A. . Antibacterial susceptibility tests: Dilution and disk diffusion methods. 2005; : 221-36
  • 21. Monsen T, Ronnmark M, Olofsson C, Wistrom J. An inexpensive and reliable method for routine identification of staphylococcal species. Eur J Clin Microbiol Infect Dis. 1998; 17(5): 327-35[PubMed]
  • 22. Performance standards for antimicrobial susceptibility testing. 2010;
  • 23. May L, Klein EY, Rothman RE, Laxminarayan R. Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012. Antimicrob Agents Chemother. 2014; 58(3): 1404-9[DOI][PubMed]
  • 24. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 25. Shakeri F, Shojai A, Golalipour M, Rahimi Alang S, Vaez H, Ghaemi EA. Spa Diversity among MRSA and MSSA Strains of Staphylococcus aureus in North of Iran. Int J Microbiol. 2010; 2010[DOI][PubMed]
  • 26. Azimian A, Havaei SA, Fazeli H, Naderi M, Ghazvini K, Samiee SM, et al. Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. J Clin Microbiol. 2012; 50(11): 3581-5[DOI][PubMed]
  • 27. Rahbar M, Mohammad-Zadeh M, Asl H, Azimi L, Lari A. Detection prevalence of inducible clindamycin resistance in Coagulase-Negative Staphylococci (CoNS) isolates in an Iranian 1000-bed tertiary Care Hospital Using D Test. Health med. 2012; 6(8): 2642-6
  • 28. Sivadon V, Rottman M, Chaverot S, Quincampoix JC, Avettand V, de Mazancourt P, et al. Use of genotypic identification by sodA sequencing in a prospective study to examine the distribution of coagulase-negative Staphylococcus species among strains recovered during septic orthopedic surgery and evaluate their significance. J Clin Microbiol. 2005; 43(6): 2952-4[DOI][PubMed]
  • 29. Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res. 2009; 164(4): 404-10[DOI][PubMed]
  • 30. Pinheiro L, Brito CI, de Oliveira A, Martins PY, Pereira VC, da Cunha Mde L. Staphylococcus epidermidis and Staphylococcus haemolyticus: Molecular Detection of Cytotoxin and Enterotoxin Genes. Toxins (Basel). 2015; 7(9): 3688-99[DOI][PubMed]
  • 31. Czekaj T, Ciszewski M, Szewczyk EM. Staphylococcus haemolyticus - an emerging threat in the twilight of the antibiotics age. Microbiology. 2015; 161(11): 2061-8[DOI][PubMed]
  • 32. Singh S, Banerjee G, Agarwal SK, Kumar M, Singh RK. Simple method for speciation of clinically significant coagulase negative Staphylococci and its antibiotic sensitivity/resistant pattern in NICU of tertiary care centre. Biomed Res. 2008; 19(2): 97-101
  • 33. Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract. 2012; 2012
  • 34. Cuevas O, Cercenado E, Vindel A, Guinea J, Sanchez-Conde M, Sanchez-Somolinos M, et al. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother. 2004; 48(11): 4240-5[DOI][PubMed]
  • 35. Sheikh AF, Mehdinejad M. Identification and determination of coagulase-negative Staphylococci species and antimicrobial susceptibility pattern of isolates from clinical specimens. Afr J Microbiol Res. 2012; 6(8): 1669-74
  • 36. Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A, et al. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother. 2004; 53(6): 1018-32[DOI][PubMed]
  • 37. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RJ, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004; 42(6): 2398-402[DOI][PubMed]
  • 38. Baddour LM, Wilson WR, Bayer AS, Fowler VJ, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111(23): 394-434[DOI][PubMed]
  • 39. Garcia de la Maria C, Cervera C, Pericas JM, Castaneda X, Armero Y, Soy D, et al. Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration. PLoS One. 2015; 10(5): 125818[DOI][PubMed]
  • 40. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RJ, Craig WA, Billeter M, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009; 29(11): 1275-9[PubMed]
  • 41. Garcia-de-la-Maria C, Marco F, Armero Y, Soy D, Moreno A, del Rio A, et al. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. Antimicrob Agents Chemother. 2010; 54(7): 2781-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments